LIXTE Trademark

Trademark Overview

On Thursday, September 11, 2014, a trademark application was filed for LIXTE with the United States Patent and Trademark Office. The USPTO has given the LIXTE trademark a serial number of 86392370. The federal status of this trademark filing is SECTION 8 - ACCEPTED as of Friday, August 20, 2021. This trademark is owned by Lixte Biotechnology Holdings, Inc.. The LIXTE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development in the pharmaceutical and biotechnology fields
lixte

General Information

Serial Number86392370
Word MarkLIXTE
Filing DateThursday, September 11, 2014
Status701 - SECTION 8 - ACCEPTED
Status DateFriday, August 20, 2021
Registration Number4723572
Registration DateTuesday, April 21, 2015
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 3, 2015

Trademark Statements

Goods and ServicesResearch and development in the pharmaceutical and biotechnology fields

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, September 19, 2014
Primary Code042
First Use Anywhere DateTuesday, May 24, 2005
First Use In Commerce DateTuesday, January 31, 2012

Trademark Owner History

Party NameLixte Biotechnology Holdings, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressEast Setauket, US 11733
Party NameLixte Biotechnology Holdings, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressEast Setauket, US 11733
Party NameLixte Biotechnology Holdings, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressEast Setauket, US 11733

Trademark Events

Event DateEvent Description
Monday, September 15, 2014NEW APPLICATION ENTERED
Wednesday, January 14, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 3, 2015PUBLISHED FOR OPPOSITION
Tuesday, February 3, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 21, 2015REGISTERED-PRINCIPAL REGISTER
Tuesday, April 21, 2020COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Monday, April 19, 2021TEAS SECTION 8 RECEIVED
Friday, September 19, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, December 23, 2014ASSIGNED TO EXAMINER
Tuesday, December 23, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, August 20, 2021CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, August 20, 2021REGISTERED - SEC. 8 (6-YR) ACCEPTED
Friday, August 20, 2021NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Thursday, February 10, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, February 10, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, February 10, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, April 4, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, April 4, 2022TEAS SECTION 15 RECEIVED
Monday, April 4, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, April 4, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, April 4, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Sunday, April 21, 2024COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Sunday, August 21, 2022SEC. 15 ACKNOWLEDGEMENT - E-MAILED
Monday, April 4, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, August 16, 2022CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Sunday, August 21, 2022REGISTERED - SEC. 15 ACKNOWLEDGED

Related Keywords

lixte fields biotechnology pharmaceutical development research